Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate

Awareness of the management of coronavirus disease 2019 (COVID-19) and airway diseases can effectively help clinical physician during the coronavirus pandemic. Herein, we elucidated a COVID-19 case coexisting with severe asthma. Budesonide/glycopyrrolate/formoterol fumarate (BGF) was used as sequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yingjian, Chen, Meizhu, Tan, Cuiyan, Tu, Changli, Zheng, Xiaobin, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869710/
https://www.ncbi.nlm.nih.gov/pubmed/33568936
http://dx.doi.org/10.2147/IJGM.S291695
_version_ 1783648680811692032
author Liang, Yingjian
Chen, Meizhu
Tan, Cuiyan
Tu, Changli
Zheng, Xiaobin
Liu, Jing
author_facet Liang, Yingjian
Chen, Meizhu
Tan, Cuiyan
Tu, Changli
Zheng, Xiaobin
Liu, Jing
author_sort Liang, Yingjian
collection PubMed
description Awareness of the management of coronavirus disease 2019 (COVID-19) and airway diseases can effectively help clinical physician during the coronavirus pandemic. Herein, we elucidated a COVID-19 case coexisting with severe asthma. Budesonide/glycopyrrolate/formoterol fumarate (BGF) was used as sequential medicine to systemic glucocorticoids for his persisted symptoms related to bronchospasms. Our case suggests patients with long-term airway diseases like asthma probably attribute their symptoms to COVID-19 instead of primary diseases, which make it more difficult in the symptom control. BGF is able to be an effective and convenient choice as sequential medicine to systemic glucocorticoids in some refractory asthmatic patients complicated with COVID-19.
format Online
Article
Text
id pubmed-7869710
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-78697102021-02-09 Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate Liang, Yingjian Chen, Meizhu Tan, Cuiyan Tu, Changli Zheng, Xiaobin Liu, Jing Int J Gen Med Case Report Awareness of the management of coronavirus disease 2019 (COVID-19) and airway diseases can effectively help clinical physician during the coronavirus pandemic. Herein, we elucidated a COVID-19 case coexisting with severe asthma. Budesonide/glycopyrrolate/formoterol fumarate (BGF) was used as sequential medicine to systemic glucocorticoids for his persisted symptoms related to bronchospasms. Our case suggests patients with long-term airway diseases like asthma probably attribute their symptoms to COVID-19 instead of primary diseases, which make it more difficult in the symptom control. BGF is able to be an effective and convenient choice as sequential medicine to systemic glucocorticoids in some refractory asthmatic patients complicated with COVID-19. Dove 2021-02-04 /pmc/articles/PMC7869710/ /pubmed/33568936 http://dx.doi.org/10.2147/IJGM.S291695 Text en © 2021 Liang et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Case Report
Liang, Yingjian
Chen, Meizhu
Tan, Cuiyan
Tu, Changli
Zheng, Xiaobin
Liu, Jing
Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate
title Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate
title_full Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate
title_fullStr Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate
title_full_unstemmed Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate
title_short Successful Sequential Treatment for Severe Asthma Coexisting COVID-19 via Budesonide/Glycopyrrolate/Formoterol Fumarate
title_sort successful sequential treatment for severe asthma coexisting covid-19 via budesonide/glycopyrrolate/formoterol fumarate
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869710/
https://www.ncbi.nlm.nih.gov/pubmed/33568936
http://dx.doi.org/10.2147/IJGM.S291695
work_keys_str_mv AT liangyingjian successfulsequentialtreatmentforsevereasthmacoexistingcovid19viabudesonideglycopyrrolateformoterolfumarate
AT chenmeizhu successfulsequentialtreatmentforsevereasthmacoexistingcovid19viabudesonideglycopyrrolateformoterolfumarate
AT tancuiyan successfulsequentialtreatmentforsevereasthmacoexistingcovid19viabudesonideglycopyrrolateformoterolfumarate
AT tuchangli successfulsequentialtreatmentforsevereasthmacoexistingcovid19viabudesonideglycopyrrolateformoterolfumarate
AT zhengxiaobin successfulsequentialtreatmentforsevereasthmacoexistingcovid19viabudesonideglycopyrrolateformoterolfumarate
AT liujing successfulsequentialtreatmentforsevereasthmacoexistingcovid19viabudesonideglycopyrrolateformoterolfumarate

Ejemplares similares